Hesperidin alleviates vascular dysfunction and remodelling in high-fat/high-fructose diet-fed rats by modulating oxidative stress, inflammation, AdipoR1, and eNOS expression

Tissue Cell. 2022 Oct:78:101901. doi: 10.1016/j.tice.2022.101901. Epub 2022 Aug 19.

Abstract

Hesperidin, a flavanone glycoside, has shown antihypertensive, antioxidant, and anti-inflammatory effects. In the present study, the therapeutic effects of hesperidin on vascular function and remodelling, and possible underlying mechanisms involved in high-fat/high-fructose diet (HFFD)-fed rats were investigated. Male Sprague-Dawley rats were fed a high-fat diet plus 15% fructose in drinking water for 16 weeks. HFFD-fed rats were treated with hesperidin (30 mg/kg/day) or vehicle for the last 4 weeks. Treatment of HFFD-fed rats with hesperidin significantly attenuated metabolic alterations, vascular endothelial dysfunction and remodelling. Hesperidin markedly alleviated HFFD-induced oxidative stress and inflammation by decreasing plasma malondialdehyde level and aortic superoxide anion production, and by suppressing aortic tumor necrosis factor-α and interleukin-6 overexpression. Additionally, increased plasma levels of the adiponectin and nitric oxide metabolite, together with restoration of adiponectin receptor 1 (AdipoR1) and endothelial nitric oxide synthase (eNOS) protein expression, were also observed after treatment with hesperidin. These findings indicated that hesperidin alleviates HFFD-induced vascular dysfunction and remodelling in rats. The possible underlying mechanism may involve the reduction of oxidative stress and inflammation, and the restoration of AdipoR1and eNOS expression.

Keywords: Adiponectin receptor 1; Endothelial nitric oxide synthase; Hesperidin; High-fat/high-fructose diet; Inflammation; Oxidative stress.

MeSH terms

  • Adiponectin / metabolism
  • Adiponectin / pharmacology
  • Adiponectin / therapeutic use
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use
  • Antioxidants / metabolism
  • Diet, High-Fat
  • Drinking Water*
  • Fructose
  • Hesperidin* / pharmacology
  • Hesperidin* / therapeutic use
  • Inflammation / drug therapy
  • Inflammation / pathology
  • Interleukin-6 / pharmacology
  • Male
  • Malondialdehyde
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type III / metabolism*
  • Oxidative Stress
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adiponectin / metabolism*
  • Receptors, Adiponectin / therapeutic use
  • Superoxides / pharmacology
  • Superoxides / therapeutic use
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Adiponectin
  • Anti-Inflammatory Agents
  • Antihypertensive Agents
  • Antioxidants
  • Drinking Water
  • Interleukin-6
  • Receptors, Adiponectin
  • Tumor Necrosis Factor-alpha
  • adiponectin receptor 1, rat
  • Superoxides
  • Fructose
  • Nitric Oxide
  • Malondialdehyde
  • Hesperidin
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat